首页 › 基金 › CONTINENTAL ADVISORS LLC › TEVA
CONTINENTAL ADVISORS LLC 对 TEVA 的持仓历史
TEVA PHARMACEUTICAL INDS LTD · 医疗保健
CONTINENTAL ADVISORS LLC 在 Q3 2026 的 13F 申报中披露持有 TEVA(TEVA PHARMACEUTICAL INDS LTD)40,000 股,市值约 US$1.6M,约占其申报组合的 0.86%,在其申报持仓中市值排名第 30 位。 CONTINENTAL ADVISORS LLC 最近 13 个申报季度中有 13 个季度披露了 TEVA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-15 · 来源: SEC EDGAR Form 13F-HR
CONTINENTAL ADVISORS LLC 对 TEVA 的持仓演变
CONTINENTAL ADVISORS LLC 于 Q3 2023 首次披露 TEVA 持仓:155,400 股(约 US$1.6M)。 该持仓在 Q4 2025 达到峰值 288,118 股,市值约 US$9.0M。 在 13 次申报中,CONTINENTAL ADVISORS LLC 2 次增持、7 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 40,000 股、市值约 US$1.6M,环比减持 -192,118 股。。 持仓曾出现大幅变动:Q4 2023 增持约 97% (随后一个季度股价上涨 35%)、Q1 2024 增持约 56% (随后一个季度股价上涨 15%)、Q3 2026 减持约 83% (随后一个季度股价上涨 6%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 155.40K | $1.59M | 新进 |
| Q4 2023 | 305.40K | $3.19M | 增持 |
| Q1 2024 | 477.77K | $6.74M | 增持 |
| Q2 2024 | 403.77K | $6.56M | 减持 |
| Q3 2024 | 361.62K | $6.52M | 减持 |
| Q4 2024 | 341.12K | $7.52M | 减持 |
| Q1 2025 | 341.12K | $5.24M | 持有 |
| Q2 2025 | 341.12K | $5.72M | 持有 |
| Q3 2025 | 341.12K | $6.89M | 持有 |
| Q4 2025 | 288.12K | $8.99M | 减持 |
| Q1 2026 | 242.12K | $7.29M | 减持 |
| Q2 2026 | 232.12K | $7.86M | 减持 |
| Q3 2026 | 40.00K | $1.58M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 TEVA 与 13F 数据
TEVA(TEVA PHARMACEUTICAL INDS LTD)属于医疗保健行业。我们追踪的基金中还有 43 只申报持有 TEVA,申报仓位最大的包括:Harel Insurance Investments & Financial Services Ltd. (US$1.63B), Phoenix Financial Ltd. (US$1.45B), WCM INVESTMENT MANAGEMENT, LLC (US$1.38B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 TEVA 的基金
- Harel Insurance Investments & Financial Services Ltd. 48.14M 股 · $1.63B · Q2 2026
- Phoenix Financial Ltd. 42.93M 股 · $1.45B · Q2 2026
- WCM INVESTMENT MANAGEMENT, LLC 41.32M 股 · $1.38B · Q2 2026
- Clal Insurance Enterprises Holdings Ltd 40.61M 股 · $1.37B · Q2 2026
- MENORA MIVTACHIM HOLDINGS LTD. 39.85M 股 · $1.35B · Q2 2026
- Migdal Insurance & Financial Holdings Ltd. 38.92M 股 · $1.32B · Q2 2026
- Lingotto Investment Management LLP 20.21M 股 · $684.58M · Q2 2026
- Rubric Capital Management LP 15.57M 股 · $527.68M · Q2 2026
- Altshuler Shaham Ltd 12.47M 股 · $411.81M · Q2 2026
- MEITAV INVESTMENT HOUSE LTD 9.95M 股 · $336.88M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 6.59M 股 · $223.37M · Q2 2026
- Alyeska Investment Group, L.P. 6.26M 股 · $212.01M · Q2 2026
更多关于 CONTINENTAL ADVISORS LLC
常见问题
How long has CONTINENTAL ADVISORS LLC held TEVA?
CONTINENTAL ADVISORS LLC has disclosed TEVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is CONTINENTAL ADVISORS LLC's current position in TEVA?
As of Q3 2026, CONTINENTAL ADVISORS LLC holds 40.00K shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $1.58M, representing 0.86% of its reported portfolio and ranking #30.
Has CONTINENTAL ADVISORS LLC been buying or selling TEVA?
In the latest 13F filing (Q3 2026), CONTINENTAL ADVISORS LLC reduced its position in TEVA. The position peaked in Q4 2025 at 288.12K shares.
Which other funds hold TEVA?
Other major institutional holders of TEVA include Harel Insurance Investments & Financial Services Ltd., Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.